LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population

BACKGROUND: The development of a safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection is a critical component of elimination efforts, providing the rationale for the first HCV vaccine efficacy trial. METHODS: In a randomized, multicenter, double-blind, placebo-controlled e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Andrea L, Page, Kimberly, Melia, Michael, Veenhuis, Rebecca, Massaccesi, Guido, Osburn, William, Wagner, Katherine, Giudice, Linda, Stein, Ellen, Asher, Alice K, Vassilev, Ventzislav, Lin, Lan, Nicosia, Alfredo, Capone, Stefania, Scarselli, Elisa, Folgori, Antonella, Gorman, Richard, Chang, Soju, Wolff, Peter, Liang, T Jake, Ghany, Marc, Wierzbicki, Michael, Lum, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809985/
http://dx.doi.org/10.1093/ofid/ofz415.2493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809985/
http://dx.doi.org/10.1093/ofid/ofz415.2493

Ejemplares similares